ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,532Medicare Part D Prescriptions Filled, Including Refills

Rank: 318 out of 3647

$1.04M Total Retail Price of All Prescriptions

Rank: 200 out of 3647

702 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 702 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

4% of this provider’s 702 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

2% of this provider’s 15,062 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 743 639 1 3
SIMVASTATIN 415 351 2 1
LISINOPRIL 394 337 3 4
METFORMIN HCL 359 302 4 6
DONEPEZIL HCL 320 315 5 30
AMLODIPINE BESYLATE 277 237 6 2
LANTUS 268 215 7 59
IBUPROFEN 265 218 8 55
NEXIUM 263 242 9 44
ATENOLOL 251 208 10 10
NAMENDA 243 243 11 49
FUROSEMIDE 243 225 11 8
METOPROLOL TARTRATE 242 224 13 7
LEVOTHYROXINE SODIUM 241 208 14 5
CRESTOR 238 204 15 19
LIDODERM 235 196 16 108
ZOLPIDEM TARTRATE 234 196 17 14
CLOPIDOGREL 233 210 18 26
PLAVIX 221 195 19 39
INSULIN SYRINGE 210 197 20 76
TRAMADOL HCL 205 168 21 22
ALENDRONATE SODIUM 195 174 22 23
NOVOLIN 70-30 194 165 23 130
WARFARIN SODIUM 191 156 24 15
GABAPENTIN 185 129 25 17
RANITIDINE HCL 183 150 26 29
SINGULAIR 179 165 27 90
VOLTAREN 175 152 28 102
POTASSIUM CHLORIDE 167 152 29 24
LISINOPRIL-HYDROCHLOROTHIAZIDE 162 134 30 36
HYDROCHLOROTHIAZIDE 159 150 31 9
CITALOPRAM HBR 159 139 31 25
CARVEDILOL 158 148 33 20
ADVAIR DISKUS 158 129 33 52
MEGESTROL ACETATE 149 137 R 35 138
DIOVAN 149 143 35 40
ENALAPRIL MALEATE 139 122 37 35
KETOCONAZOLE 130 100 38 132
DICLOFENAC SODIUM 130 117 38 86
LOSARTAN POTASSIUM 125 125 40 11
FAMOTIDINE 123 111 41 61
ATORVASTATIN CALCIUM 121 105 42 13
DIOVAN HCT 118 109 43 80
SERTRALINE HCL 117 97 44 27
MUPIROCIN 117 101 44 137
ALPRAZOLAM 114 88 46 31
TRIAMTERENE-HCTZ 113 111 47 58
FLUTICASONE PROPIONATE 111 103 48 32
TAMSULOSIN HCL 108 103 49 28
LACTULOSE 108 92 49 128
AZITHROMYCIN 107 79 51 34
SILVER SULFADIAZINE 106 103 52 243
NITROGLYCERIN PATCH 97 97 53 203
GLIPIZIDE 96 82 54 41
CELEBREX 96 94 54 111
PROAIR HFA 95 86 56 62
TRICOR 95 55 56 144
SURE COMFORT 93 81 58 161
DICYCLOMINE HCL 91 68 59 194
SEROQUEL 90 79 60 185
DIGOXIN 88 82 61 51
QUETIAPINE FUMARATE 86 75 62 89
AMMONIUM LACTATE 84 82 63 141
CLOTRIMAZOLE-BETAMETHASONE 82 78 64 84
PAROXETINE HCL 80 76 65 60
ESCITALOPRAM OXALATE 79 68 66 65
TRIAMTERENE-HYDROCHLOROTHIAZID 79 65 66 223
GEMFIBROZIL 78 65 68 82
FINASTERIDE 77 76 69 66
LOSARTAN-HYDROCHLOROTHIAZIDE 74 65 70 48
ISOSORBIDE MONONITRATE ER 69 59 71 56
HYDROCODONE-ACETAMINOPHEN 69 21 S3 71 12
TRAZODONE HCL 67 51 73 64
BUMETANIDE 67 67 73 134
PENTOXIFYLLINE 66 66 75 180
GLYBURIDE 66 62 R 75 54
CARBIDOPA-LEVODOPA 64 64 77 127
LEVETIRACETAM 64 48 77 122
CYCLOBENZAPRINE HCL 63 45 R 79 98
METOCLOPRAMIDE HCL 63 44 79 135
BACLOFEN 63 43 79 97
ATENOLOL-CHLORTHALIDONE 62 53 82 171
NAPROXEN 62 53 82 70
MONTELUKAST SODIUM 60 54 84 160
METOPROLOL SUCCINATE 59 53 85 18
BENZTROPINE MESYLATE 59 48 R 85 222
NIFEDIPINE ER 58 54 87 67
NOVOLIN R 58 58 87 139
RISPERIDONE 56 50 89 83
ACTOS 54 26 90 148
TEMAZEPAM 53 29 91 47
LEXAPRO 53 43 91 177
LATANOPROST 53 53 91 218
TERAZOSIN HCL 51 41 94 103
MELOXICAM 50 42 95 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 13, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.